Literature DB >> 1436116

Isolation of the first crystalline D-penicillamine complex of iron and some remarks on relevant aspects of metal-chelating drugs as well as metabolism disorders.

A Müller1, M Straube, E Krickemeyer, H Bögge.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1436116     DOI： 10.1007/bf01138712

Source DB:  PubMed          Journal:  Naturwissenschaften        ISSN： 0028-1042


× No keyword cloud information.
  9 in total

1.  Effect of penicillamine on some metals and metalloproteins in the rat.

Authors:  V Albergoni; A Cassini; N Favero; G P Rocco
Journal:  Biochem Pharmacol       Date:  1975-05-15       Impact factor: 5.858

2.  Penicillamine, a new oral therapy for Wilson's disease.

Authors:  J M WALSHE
Journal:  Am J Med       Date:  1956-10       Impact factor: 4.965

3.  Structure, properties, and function of a copper(I)-copper(II) complex of D-penicillamine: pentathallium(I) mu8-chloro-dodeca (D-penicillaminato)-octacuprate(I)hexacuprate(II) n-hydrate.

Authors:  P J Birker; H C Freeman
Journal:  J Am Chem Soc       Date:  1977-10-12       Impact factor: 15.419

4.  [Antioxidative activity of antiarthritic preparations].

Authors:  V A Kostiuk; A I Potapovich; N F Soroka
Journal:  Vopr Med Khim       Date:  1990 May-Jun

5.  D-penicillamine inhibits transactivation of human immunodeficiency virus type-1 (HIV-1) LTR by transactivator protein.

Authors:  A Chandra; I Demirhan; S K Arya; P Chandra
Journal:  FEBS Lett       Date:  1988-08-29       Impact factor: 4.124

6.  [D-Penacillamine. From constituent of penicillins to significant drug].

Authors:  E Lodemann
Journal:  Naturwissenschaften       Date:  1979-09

7.  Effect of D-penicillamine on iron uptake by isolated rat hepatocytes.

Authors:  R Rama; J Sánchez
Journal:  Biol Trace Elem Res       Date:  1988-12       Impact factor: 3.738

8.  The formation and nature of the mixed valence copper-D-penicillamine-chloride cluster in aqueous solution and its relevance to the treatment of Wilson's disease.

Authors:  S H Laurie; D M Prime
Journal:  J Inorg Biochem       Date:  1979-11       Impact factor: 4.155

9.  Defective gallium-transferrin binding in Alzheimer disease and Down syndrome: possible mechanism for accumulation of aluminium in brain.

Authors:  G Farrar; P Altmann; S Welch; O Wychrij; B Ghose; J Lejeune; J Corbett; V Prasher; J A Blair
Journal:  Lancet       Date:  1990-03-31       Impact factor: 79.321
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.